Skip to content

Clinical trials

Intracranial Aneurysm trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intracranial Aneurysm Country / region: China Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20091
20103
20123
20131
20141
20151
201611
20174
20184
20191
20201
20217
20227
202320
20248
20254
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status38
Completed22
Recruiting20
Not yet recruiting4
Active, not recruiting4
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital17
MicroPort NeuroTech Co., Ltd.8
Beijing Neurosurgical Institute5
Xuanwu Hospital, Beijing5
Second Affiliated Hospital, Zhejiang University, School of Medicine4
The First Affiliated Hospital with Nanjing Medical University4
Ton-Bridge Medical Tech. Co., Ltd4
Duan Chuanzhi3
Shanghai Jiao Tong University School of Medicine3
Stryker Neurovascular3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intracranial Aneurysm90
Subarachnoid Hemorrhage8
Ischemic Stroke5
Aneurysm4
Brain Diseases4
Arteriovenous Malformations3
Cardiovascular Diseases3
Intracranial Arteriovenous Malformations3
Bites and Stings2
Cerebral Hemorrhage2

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.